|
[1]
|
Lipton, R.B., Bigal, M.E., Diamond, M., Freitag, F., Reed, M.L. and Stewart, W.F. (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68, 343-349.
doi:10.1212/01.wnl.0000252808.97649.21
|
|
[2]
|
Lipton, R.B. and Stewart, W.F. (1997) Prevalence and impact of migraine. Neurologic Clinics, 15, 1-13.
doi:10.1016/S0733-8619(05)70291-7
|
|
[3]
|
Hawkins, K., Wang, S. and Rupnow, M.F. (2007) Indirect cost burden of migraine in the United States. Journal of Occupational and Environmental Medicine, 49, 368-374. doi:10.1097/JOM.0b013e31803b9510
|
|
[4]
|
Hawkins, K., Wang, S. and Rupnow, M. (2008) Direct cost burden among insured US employees with migraine. Headache, 48, 553-563.
doi:10.1111/j.1526-4610.2007.00990.x
|
|
[5]
|
Mulder, E.J., Van Baal, C., Gaist, D., Kallela, M., Kaprio, J., Svensson, D.A, et al. (2003) Genetic and environmental influences on migraine: A twin study across six countries. Twin Research, 6, 422-431.
|
|
[6]
|
Wessman, M., Terwindt, G.M., Kaunisto, M.A., Palotie, A. and Ophoff, R.A. (2007) Migraine: A complex genetic disorder. Lancet Neurology, 6, 521-532.
doi:10.1016/S1474-4422(07)70126-6
|
|
[7]
|
Couturier, E.G., Bomhof, M.A., Neven, A.K. and van Duijn, N.P. (2003) Menstrual migraine in a representative Dutch population sample: Prevalence, disability and treatment. Cephalalgia, 23, 302-308.
doi:10.1046/j.1468-2982.2003.00516.x
|
|
[8]
|
Gupta, S., Mehrotra, S., Villalon, C.M., Perusquia, M., Saxena, P.R. and Maassen Van Den Brink, A. (2007) Potential role of female sex hormones in the pathophysiology of migraine. Pharmacology & Therapeutics, 113, 321-340. doi:10.1016/j.pharmthera.2006.08.009
|
|
[9]
|
MacGregor, E.A., Chia, H., Vohrah, R.C. and Wilkinson, M. (1990) Migraine and menstruation: A pilot study. Cephalalgia, 10, 305-310.
doi:10.1046/j.1468-2982.1990.1006305.x
|
|
[10]
|
MacGregor, E.A. (2004) Oestrogen and attacks of migraine with and without aura. Lancet Neurology, 3, 354-361. doi:10.1016/S1474-4422(04)00768-9
|
|
[11]
|
Martin, V.T. and Lipton, R.B. (2008) Epidemiology and biology of menstrual migraine. Headache, 48, S124-S130. doi:10.1111/j.1526-4610.2008.01310.x
|
|
[12]
|
MacGregor, E.A. (1996) “Menstrual” migraine: Towards a definition. Cephalalgia, 16, 11-21.
doi:10.1046/j.1468-2982.1996.1601011.x
|
|
[13]
|
Stewart, W.F., Lipton, R.B., Chee, E., Sawyer, J. and Silberstein, S.D. (2000) Menstrual cycle and headache in a population sample of migraineurs. Neurology, 55, 1517-1523. doi:10.1212/WNL.55.10.1517
|
|
[14]
|
Martin, V.T., Lee, J. and Behbehani, M.M. (2007) Sensi-tization of the trigeminal sensory system during different stages of the rat estrous cycle: Implications for menstrual migraine. Headache, 47, 552-563.
|
|
[15]
|
Varlibas, A. and Erdemoglu, A.K. (2009) Altered trige-minal system excitability in menstrual migraine patients. Journal of Headache and Pain, 10, 277-282.
doi:10.1007/s10194-009-0132-4
|
|
[16]
|
Joshi, G., Pradhan, S. and Mittal, B. (2010) Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia, 30, 311-320.
|
|
[17]
|
Oterino, A., Toriello, M., Cayon, A., Castillo, J., Colas, R., Alonson-Arranz, A., et al. (2008) Multilocus analyses reveal involvement of the ESR1, ESR2 and FSHR genes in migraine. Headache, 48, 1438-1450.
doi:10.1111/j.1526-4610.2008.01294.x
|
|
[18]
|
Lee, H., Sininger, L., Jen, J.C., Cha, Y.H., Baloh, R.W. and Nelson, S.F. (2007) Association of progesterone receptor with migraine-associated vertigo. Neurogenetics, 8, 195-200. doi:10.1007/s10048-007-0091-3
|
|
[19]
|
Oterino, A., Pascual, J., Ruiz de Alegria, C., Valle, N., Castillo, J., Bravo, Y., et al. (2006) Association of migraine and ESR1 G325C polymorphism. NeuroReport, 17, 61-64. doi:10.1097/01.wnr.0000192735.85287.f4
|
|
[20]
|
Colson, N.J., Lea, R.A., Quinlan, S., MacMillan, J. and Griffiths, L.R. (2005) Investigation of hormone receptor genes in migraine. Neurogenetics, 6, 17-23.
doi:10.1007/s10048-004-0205-0
|
|
[21]
|
Colson, N.J., Lea, R.A., Quinlan, S., MacMillan, J. and Griffiths, L.R. (2004) The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics, 5, 129-133. doi:10.1007/s10048-004-0181-4
|
|
[22]
|
Silberstein, S.D. and Merriam, G.R. (2000) Physiology of the menstrual cycle. Cephalalgia, 20, 148-154.
doi:10.1046/j.1468-2982.2000.00034.x
|
|
[23]
|
Zacur, H.A. (2006) Hormonal changes throughout life in women. Headache, 46, S49-S54.
doi:10.1111/j.1526-4610.2006.00554.x
|
|
[24]
|
Martin, V.T. and Behbehani, M. (2006) Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis: Part I. Headache, 46, 3-23.
doi:10.1111/j.1526-4610.2006.00309.x
|
|
[25]
|
Martin, V.T. and Behbehani, M. (2006) Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis: Part 2. Headache, 46, 365-386.
doi:10.1111/j.1526-4610.2006.00370.x
|
|
[26]
|
Speroff, L. and Fritz, M.A. (2005) Clinical Gynecologic Endocrinology and Infertility. 7th Edition, Lippincott Williams & Wilkins, Philadelphia.
|
|
[27]
|
Nahmias, J., Burley, M.W., Povey, S., Porter, C., Craig, I. and Wolfe, J. (1992) A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus. Human Molecular Genetics, 1, 286. doi:10.1093/hmg/1.4.286
|
|
[28]
|
Ebstein, R.P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., et al. (1996) Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature Genetics, 12, 78-80. doi:10.1038/ng0196-78
|
|
[29]
|
Emin Erdal, M., Herken, Y., Yilmaz, M. and Bayazit, Y.A. (2001) Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Research. Molecular Brain Research, 94, 193-196.
doi:10.1016/S0169-328X(01)00219-4
|
|
[30]
|
Park, J.W., Lee, K.S., Kim, J.S., Kim, Y.I. and Shin, H.E. (2007) Genetic contribution of catechol-o-methyltransferase polymorphism in patients with migraine without aura. Journal of Clinical Neurology, 3, 24-30.
doi:10.3988/jcn.2007.3.1.24
|
|
[31]
|
Corominas, R., Ribases, M., Camina, M., Cuenca-Leon, E., Pardo, J., Boronat, S., et al. (2009) Two-stage casecontrol association study of dopamine-related genes and migraine. BMC Medical Genetics, 10, 95.
doi:10.1186/1471-2350-10-95
|
|
[32]
|
Todt, U., Netzer, C., Toliat, M., Heinze, A., Goebel, I., Nurnberg, P., et al. (2009) New genetic evidence for involvement of the dopamine system in migraine with aura. Human Genetics, 125, 265-279.
doi:10.1007/s00439-009-0623-z
|
|
[33]
|
Corominas, R., Sobrido, M.J., Ribases, M., Cuenca-Leon, E., Blanco-Arias, P., Narberhaus, B., et al. (2010) Association study of the serotoninergic system in migraine in the Spanish population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 153B, 177-184.
|
|
[34]
|
Fernandez, F., Colson, N., Quinlan, S., MacMillan, J., Lea, R.A. and Griffiths, L.R. (2009) Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus. Neurogenetics, 10, 199-208.
doi:10.1007/s10048-009-0176-2
|
|
[35]
|
Fernandez, F., Lea, R.A., Colson, N.J., Bellis, C., Quinlan, S. and Griffiths, L.R. (2006) Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. Journal of the Neurological Sciences, 251, 118-123.
doi:10.1016/j.jns.2006.09.013
|
|
[36]
|
Lea, R.A., Dohy, A., Jordan, K., Quinlan, S., Brimage, P.J. and Griffiths, L.R. (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics, 3, 35-40.
|
|
[37]
|
Mochi, M., Cevoli, S., Cortelli, P., Pierangeli, G., Soriani, S., Scapoli, C., et al. (2003) A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurological Sciences, 23, 301-305. doi:10.1007/s100720300005
|
|
[38]
|
Peroutka, S.J., Wilhoit, T. and Jones, K. (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology, 49, 201-206. doi:10.1212/WNL.49.1.201
|
|
[39]
|
Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders. 2nd Edition, Cephalalgia, 24, 24-36.
|
|
[40]
|
Wood, P.B. (2008) Role of central dopamine in pain and analgesia. Expert Review of Neurotherapeutics, 8, 781-797. doi:10.1586/14737175.8.5.781
|
|
[41]
|
Viisanen, H., Ansah, O.B. and Pertovaara, A. (2012) The role of the dopamine D2 receptor in descending control of pain induced by motor cortex stimulation in the neuronpathic rat. Brain Research Bulletin, 89, 133-143.
doi:10.1016/j.brainresbull.2012.08.002
|
|
[42]
|
Charbit, A.R., Akerman, S. and Goadsby, P.J. (2010) Dopamine: What’s new in migraine? Current Opinion in Neurology, 23, 275-281.
doi:10.1097/WCO.0b013e3283378d5c
|
|
[43]
|
Bergerot, A., Storer, R.J. and Goadsby, P.J. (2007) Dopamine inhibits trigeminovascular transmission in the rat. Annals of Neurology, 61, 251-262.
doi:10.1002/ana.21077
|
|
[44]
|
Charbit, A.R., Akerman, S., Holland, P.R. and Goadsby, P.J. (2009) Neurons of the dopaminergic/calcitonin generelated peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: An electrophysiological and immunohistochemical study. Journal of Neuroscience, 29, 12532-12541.
doi:10.1523/JNEUROSCI.2887-09.2009
|
|
[45]
|
Kambur, O., Talka, R., Ansah, O.B., Kontinen, V.K., Pertovaara, A., Kalso, E., et al. (2010) Inhibitors of catechol-O-methyltransferase sensitize mice to pain. British Journal of Pharmacology, 161, 1553-1565.
doi:10.1111/j.1476-5381.2010.00999.x
|
|
[46]
|
Kambur, O., Mannisto, P.T., Viljakka, K., Reenila, I., Lemberg, K., Kontinen, V.K., et al. (2008) Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice. Basic & Clinical Pharmacology & Toxicology, 103, 367-373.
doi:10.1111/j.1742-7843.2008.00289.x
|
|
[47]
|
Knobil, E. and Neill, J.D. (1994) The physiology of reproduction. 2nd Edition, Raven Press, New York.
|
|
[48]
|
Panek, D.U. and Dixon, W.R. (1986) Effect of continuous intraventricular estrogen or catechol estrogen treatment on catecholamine turnover in various brain regions. Journal of Pharmacology and Experimental Therapeutics, 236, 646-652.
|
|
[49]
|
Marcano de Cotte, D., De Menezes, C.E., Bennett, G.W. and Edwardson, J.A. (1980) Dopamine stimulates the degradation of gonadotropin releasing hormone by rat synaptosomes. Nature, 283, 487-489.
doi:10.1038/283487a0
|
|
[50]
|
Zohar, Y., Munoz-Cueto, J.A., Elizur, A. and Kah, O. (2010) Neuroendocrinology of reproduction in teleost fish. General and Comparative Endocrinology, 165, 438-455. doi:10.1016/j.ygcen.2009.04.017
|
|
[51]
|
Dufour, S., Sebert, M.E., Weltzien, F.A., Rousseau, K. and Pasqualini, C. (2010) Neuroendocrine control by dopamine of teleost reproduction. Journal of Fish Biology, 76, 129-160. doi:10.1111/j.1095-8649.2009.02499.x
|
|
[52]
|
Popesku, J.T., Martyniuk, C.J., Denslow, N.D. and Trudeau, V.L. (2010) Rapid dopaminergic modulation of the fish hypothalamic transcriptome and proteome. PLoS One, 5, e12338. doi:10.1371/journal.pone.0012338
|
|
[53]
|
Rasmussen, D.D., Liu, J.H., Wolf, P.L. and Yen, S.S. (1986) Gonadotropin-releasing hormone neurosecretion in the human hypothalamus: In vitro regulation by dopamine. Journal of Clinical Endocrinology and Metabolism, 62, 479-483. doi:10.1210/jcem-62-3-479
|
|
[54]
|
Boesgaard, S., Hagen, C., Hangaard, J., Andersen, A.N. and Eldrup, E. (1991) Pulsatile gonadotropin secretion and basal prolactin levels during dopamine D-1 receptor stimulation in normal women. Fertility and Sterility, 55, 281-286.
|